756
Views
33
CrossRef citations to date
0
Altmetric
REVIEWS

Effect of Physicochemical Properties of Biodegradable Polymers on Nano Drug Delivery

, , , &
Pages 546-567 | Received 13 May 2013, Accepted 16 Jun 2013, Published online: 27 Sep 2013

References

  • Mishra , N. , Goyal , A. K. , Khatri , K. , Vaidya , B. , Paliwal , R. , Rai , S. , Mehta , A. , Tiwari , S. and Vyas , S. 2008 . Biodegradable polymer based particulate carrier(s) for the delivery of proteins and peptides . Antiinflamm. Antiallergy Agents Med. Chem. , 7 ( 4 ) : 240 – 251 .
  • Janes , K. A. , Calvo , P. and Alonso , M. J. 2001 . Polysaccharide colloidal particles as delivery systems for macromolecules . Adv. Drug Deliver. Rev. , 47 ( 1 ) : 83 – 97 .
  • Kumari , A. , Yadav , S. K. and Yadav , S. C. 2010 . Biodegradable polymeric nanoparticles based drug delivery systems . Colloids Surface B: Biointerfaces , 75 : 1 – 18 .
  • Mittal , G. , Sahana , D. K. , Bhardwaj , V. and Kumar , R. M. N. 2007 . Estradiol loaded PLGA nanoparticles for oral administration: Effect of polymer weight and copolymer composition on release behavior in vitro and in vivo . J. Control. Release , 119 : 77 – 85 .
  • Lü , J. M. , Wang , X. , Muller , C. M. , Wang , H. , Lin , P. H. , Yao , Q. and Chen , C. 2009 . Current advances in research and clinical applications of PLGA based nanotechnology . Expert Rev. Mol. Diagn. , 9 ( 4 ) : 325 – 341 .
  • Okada , H. 1997 . One and three month release injectable microspheres of the LH-RH superagonists leuprorelin acetate . Adv. Drug Deliver. Rev. , 28 : 43 – 70 .
  • Danhier , F. , Ansorena , E. , Silva , J. M. , Coco , R. , Breton , A. L. and Préat , V. 2012 . PLGA-based nanoparticles: An overview of biomedical applications . J. Control. Release , 161 : 505 – 522 .
  • Park , J. H. , Saravanakumar , G. , Kim , K. and Kwon , I. C. 2010 . Targeted delivery of low molecular drugs using chitosan and its derivatives . Adv. Drug Deliver. Rev. , 62 ( 1 ) : 28 – 41 .
  • Dash , T. K. and Konkimalla , V. B. 2012 . Poly-ε-caprolactone based formulation for drug delivery and tissue engineering: A review . J. Control. Release , 158 : 15 – 33 .
  • Hunter , A. C. , Elsom , J. , Wibroe , P. P. and Moghimi , S. M. 2012 . Polymeric particulate technologies for oral drug delivery and targeting: A pathophysiological perspective . Nanomedicine. , 8 : S5 – S20 .
  • Parveen , S. and Misra , R. 2012 . Nanoparticles: A boon to drug delivery, therapeutics, diagnostics and imaging . Nanomedicine. , 8 : 147 – 166 .
  • Bagul , R. , Mahajan , V. and Dhake , A. 2012 . New approaches in nanoparticulate drug delivery system: A review . Int. J. Curr. Pharm. Res. , 4 ( 3 ) : 29 – 38 .
  • Jain , R. A. 2000 . The manufacturing techniques of various drug loaded biodegradable Poly(lactide-co-glycolide) (PLGA) devices . Biomaterials. , 21 : 2475 – 2490 .
  • Majeti , N. V. and Kumar , R. 2000 . Nano and microparticles as controlled drug delivery devices . J. Pharm. Pharm. Sci. , 3 ( 2 ) : 234 – 258 .
  • Kumar , P. , Meena , K. P. , Kumar , P. , Choudhary , C. , Thakur , D. S. and Bajpayee , P. 2010 . Dendrimer: A novel polymer for drug delivery . J. Innovative Trends in Pharma. Sci. , 1 ( 6 ) : 252 – 269 .
  • Peracchia , M. T. , Fattal , E. , Desmaele , D. , Besnard , M. , Neol , J. P. , Gomis , J. M. , Apple , M. , d’Angelo , J. and Couvreur , P. 1999 . Stealth PEGylated polycyanoacrylate nanoparticles for intravenous administration and splenic targeting . J. Control. Release , : 121 – 128 .
  • Vij , N. , Min , T. , Marasigan , R. , Belcher , C. N. , Mazur , S. , Ding , H. , Yong , K. T. and Roy , I. 2010 . Development of PEGylated PLGA nanoparticle for controlled and sustained drug delivery in cystic fibrosis . J. Nanobiotech. , 8 : 22
  • Lai , S. K. , Wang , Y. Y. and Hanes , J. 2009 . Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues . Adv. Drug Deliver. Rev. , 61 : 158 – 171 .
  • Dinarvand , R. , Sepehri , N. , Manoochehri , S. , Rouhani , H. and Atyabi , F. 2011 . Poly(lactide-co-glycolide) nanoparticles for controlled delivery of anticancer agents . Int. J. Nanomedicine. , 6 : 877 – 895 .
  • Meredith , L. , Lowman , Hans and Lowman , A. M. 2006 . “ Nanoparticles for drug delivery ” . In Nanomaterials Handbook Ch. 23
  • Makadia , H. K. and Siegel , S. J. 2011 . Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier . Polymers. , 3 : 1377 – 1397 .
  • Vandana , M. and Sahoo , S. K. 2010 . Long circulation and cytotoxicity of PEGylated gemcitabine and its potential for the treatment of pancreatic cancer . Biomaterials. , 3 : 9340 – 9356 .
  • Shenoy , D. B. and Amiji , M. M. 2005 . Poly(ethylene oxide)-modified poly(epsiloncaprolactone) nanoparticles for targeted delivery of tamoxifen in breast cancer . Int. J. Pharm. , 293 ( 1–2 ) : 261 – 270 .
  • Ven , H. V. D. , Vermeersch , M. , Matheeussen , A. , Vandervoort , J. , Weyenberg , W. , Aspers , S. , Cos , P. , Maes , L. and Ludwig , A. 2011 . PLGA nanoparticles loaded with the antileishmanial saponin β-aescin: Factor influence study and in vitro efficacy evaluation . Int. J. Pharm. , 420 : 122 – 132 .
  • Kim , B. K. , Hwang , S. J. and Park , J. B. 2005 . Characteristics of felodipine-located poly (e-caprolactone) microspheres . J. Microencapsul. , 22 ( 2 ) : 193 – 203 .
  • Mohammadi , G. , Valizadeh , H. , Barzegar-jalali , M. , Lotfipour , F. , Adibkia , K. , Milani , M. , Azhdarzadeh , M. , Kiafar , F. and Nokhodchi , A. 2010 . Development of azithromycin-PLGA nanoparticles: Physicochemical characterisation and antibacterial effect against Salmonella typhi . Colloids Surface B Biointerfaces , 80 : 34 – 39 .
  • Kumar , G. , Sharma , S. , Shafiq , N. , Khuller , G. K. and Malhotra , S. 2012 . Optimization, in vitro-in vivo evaluation: Short-term tolerability of novel levofloxacin-loaded PLGA nanoparticle formulation . J. Pharm. Sci. , 101 ( 6 ) : 2165 – 2176 .
  • Silva , L. C. D. , Garcia , T. , Mori , M. , Sandri , G. , Bonferoni , M. C. , Finotelli , P. V. , Cinelli , L. P. , Caramella , C. and Cabral , L. M. 2012 . Preparation and characterization of Polysaccheride-based Nanoparticles with anticoagulant activity . Int. J. Nanomedicine. , 7 : 2975 – 2986 .
  • Kumar , M. N. , Muzzarelli , R. A. , Muzzarelli , C. , Sashiwa , H. and Domb , A. J. 2004 . Chitosan chemistry and pharmaceutical perspective . Chem Rev. , 104 ( 12 ) : 6017 – 6184 .
  • Bei , Y. Y. , Chen , X. Y. , Liu , Y. , Xu , J. Y. , Wang , W. J. , Gu , Z. L. , Xing , K. L. , Zhu , A. J. , Chen , W. L. , Shi , L. S. , Wang , Q. , Zhang , X. N. and Zhang , Q. 2012 . Novel norcantharidin-loaded liver targeting chitosan nanoparticles to enhance intestinal absorption . Int. J. Nanomedicine. , 7 : 1819 – 1827 .
  • Rao , J. P. and Geckeler , K. E. 2011 . Polymeric nanoparticles: Preparation techniques and size-control parameters . Prog. Polym. Sci. , 36 : 887 – 913 .
  • Joshi , S. A. , Chavhan , S. S. and Sawant , K. K. 2010 . Rivastigmine-loaded PLGA and PBCA nanoparticles: Preparation, optimization, characterization, in vitro and pharmacodynamic studies . Eur. J. Pharm. Biopharm. , 76 : 189 – 199 .
  • Nikouei , B. M. , Tabassi , S. A. S. and Jaafari , M. R. 2006 . The effect of different grades of PLGA on characteristics of microspheres encapsulated with cyclosporine A . Curr. Drug Del. , 3 ( 4 ) : 343 – 349 .
  • Panyam , J. , Williams , D. , Dash , A. , Pelecky , D. L. and Labhasetwar , V. 2004 . Solid-state solubility influences encapsulation and release of hydrophobic drugs from plga/pla nanoparticles . J. Pharm. Sci. , 93 ( 7 ) : 1804 – 1814 .
  • Zambaux , M. F. , Bonneaux , F. , Gref , R. , Dellacherie , E. and Vigneron , C. 1999 . Preparation and characterization of protein C-loaded PLA nanoparticles . J. Control. Release , 60 ( 2–3 ) : 179 – 188 .
  • Matsumoto , J. , Nakada , Y. , Sakurai , K. , Nakamura , T. and Takahashi , Y. 1999 . Preparation of nanoparticles consisted of poly(llactide)– poly(ethylene glycol)–poly(l-lactide) and their evaluation in vitro . Int. J. Pharm. , 185 ( 1 ) : 93 – 101 .
  • Tsai , Y. M. , Liao , W. L. C. , Chien , C. F. , Lin , L. C. and Tsai , T. H. 2012 . Effects of polymer molecular weight on relative oral bioavailability of curcumin . Int. J. Nanomedicine. , 7 : 2957 – 2966 .
  • Feng , R. , Song , Z. and Zhai , G. 2012 . Preparation and in vivo pharmacokinetics of curcumin-loaded PCL-PEG-PCL triblock copolymeric nanoparticles . Int. J. Nanomedicine. , 7 : 4089 – 4098 .
  • Hans , M. L. and Lowman , A. M. 2002 . Biodegradable nanoparticles for drug delivery and targeting . Curr. Opin. Solid State Mater. Sci. , 6 : 319 – 327 .
  • Liu , Y. , Zang , H. D. , Kong , M. , Ma , F. K. , Dang , Q. F. , Cheng , X. J. , Ji , Q. X. and Chen , X. G. 2012 . In vitro evaluation of mucoadhesion and permeation enhancement of polymeric amphiphilic nanoparticles . Carbohydr. Polymer , 89 : 453 – 460 .
  • Park , K. , Kim , J. H. , Nam , Y. S. , Lee , S. , Nam , H. Y. , Kim , K. , Park , J. H. , Kim , I. S. , Choi , K. , Kim , S. Y. and Kwon , I. C. 2007 . Effect of polymer molecular weight on the tumor targeting characteristics of self- assembled glycol chitosan nanoparticles . J. Control. Release , 122 : 305 – 314 .
  • Youan , B. B. C. , Benoit , M. A. , Baras , B. and Gillard , J. 1999 . Protein -loaded poly (ϵ-caprolactone) microparticles I. Optimization of the preparation by (water -in -oil)-in water emulsion solvent evaporation . J. Microencapsul. , 16 ( 5 ) : 587 – 599 .
  • Santos , K. C. D. , Silva , M. F. , Pereira-Filho , E. R. , Fernandes , J. B. , Polikarpov , I. and Forim , M. R. 2012 . Polymeric nanoparticles loaded with the 3,5,3’-triidothyroacetic acid (Triac), a thyroid hormone: Factorial design, characterisation, and release kinetics . Nanotech. Sci. Appl. , 5 : 37 – 48 .
  • Zolnik , B. S. and Burgess , D. J. 2008 . Evaluation of in vivo–in vitro release of dexamethasone from PLGA microspheres . J. Control. Release , 127 : 137 – 145 .
  • Eldridge , J. H. , Hammond , C. J. , Meulbroek , J. A. , Staas , J. K. , Gilley , R. M. and Tice , T. R. 1990 . Controlled vaccine release in the gut-associated lymphoid-tissues-Orally administered biodegradable microspheres target the Peyer's patches . J. Control. Release , 11 : 205 – 214 .
  • Reis , C. P. , Neufeld , R. J. , Ribeiro , A. J. and Veiga , F. 2006 . Nanoencapsulation I. Method of preoaration of drug-loaded polymeric nanoparticles . Nanomedicine: Nanotech. Biol. and Medicine , 2 : 8 – 21 .
  • Bilensoy , E. , Sarisozen , C. , Esendağli , G. , Doğan , A. L. , Aktaş , Y. , Sen , M. and Mungan , N. A. 2009 . Intravesical cationic nanoparticles of chitosan and polycaprolactone for the delivery of Mitomycin C to bladder tumors . Int. J. Pharm. , 371 : 170 – 176 .
  • Derakhshandeh , K. , Erfan , M. and Dadashzadeh , S. 2007 . Encapsulation of 9-nitrocamptothecin, a novel anticancer drug, in biodegradable nanoparticles: Factorial design, characterization and release kinetics . Eur. J. Pharm. Biopharm. , 66 : 34 – 41 .
  • Abdelghany , S. M. , Quinn , D. J. , Ingram , R. J. , Gilmore , B. F. , Donnelly , R. F. , Taggart , C. C. and Scott , C. J. 2012 . Gentamicin-loaded nanoparticles show improved antimicrobial effects towards Pseudomonas aeruginosa . Int. J. Nanomedicine. , 7 : 4053 – 4063 .
  • Zaki , N. M. and Hafez , M. M. 2012 . Enhanced antibacterial effect of ceftriaxone sodium-loaded chitosan nanoparticles against intracellular Salmonella typhimurium . AAPS PharmSciTech. , 13 ( 2 ) : 411 – 421 .
  • Jeong , Y. I. , Na , H. S. , Seo , D. H. , Kim , D. G. , Lee , H. C. , Jang , M. K. , Na , S. K. , Roh , S. H. , Kim , S. I. and Nah , J. W. 2008 . Ciprofloxacin-encapsulated poly(DL-lactide-co-glycolide) nanoparticles and its antibacterial activity . Int. J. Pharm. , 352 : 317 – 323 .
  • Osuna , I. B. , Vauthier , C. , Farabollini , A. , Palmieri , G. F. and Ponchel , G. 2007 . Mucoadhesion mechanism of chitosan and thiolated chitosan-poly(isobutyl cyanoacrylate) core-shell nanoparticles . Biomaterials , 28 : 2233 – 2243 .
  • Owens , D. E. and Peppas , N. A. 2006 . Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticle . Int. J. Pharm. , 307 : 93 – 102 .
  • Tahara , K. , Sakai , T. , Yamamoto , H. , Takeuchi , H. , Hirashima , N. and Kawashima , Y. 2009 . Improved cellular uptake of chitosan-modified PLGA nanospheres by A549 cells . Int. J. Pharm. , 382 : 198 – 204 .
  • Patil , Y. B. , Swaminathan , S. K. , Sadhukha , T. , Ma , L. and Panyam , J. 2010 . The use of nanoparticle-mediated targeted gene silencing and drug delivery to overcome tumor drug resistance . Biomaterials , 31 : 358 – 365 .
  • Araujo , J. , Vega , E. , Lopes , C. , Egea , M. A. , Garcia , M. L. and Souto , E. B. 2009 . Effect of polymer viscosity on physicochemical properties and ocular tolerance of FB-loaded PLGA nanospheres . Colloids Surf B Biointerfaces , 72 : 48 – 56 .
  • Vega , E. , Gamisans , F. , Garc , M. L. , Chauvet , A. , Lacoulonche , F. and Egea , M. A. 2008 . PLGA nanospheres for the ocular delivery of flurbiprofen: Drug release and interactions . J. Pharm. Sci. , 97 : 5306 – 5531 .
  • Mittal , V. V. , Patel , S. J. and Sheth , S. K. 2010 . Development and characterization of folate targeted nanoparticle drug delivery system . Int. J. Pharma Bio. Sci. , 1 ( 2 ) : 1 – 12 .
  • Wang , Z. , Liu , W. , Huibi , X. U. and Yang , X. 2007 . Preparation and in vitro studies of stealth PEGylated PLGA nanoparticles as carriers for arsenic trioxide . Chin. J. Chem. Eng. , 15 ( 6 ) : 795 – 801 .
  • Sheng , Y. , Liu , C. , Yuan , Y. , Tao , X. , Yang , F. , Shan , X. , Zhou , H. and Xu , F. 2009 . Long-circulating polymeric nanoparticles bearing a combinatorial coating of PEG and water-soluble chitosan . Biomaterials. , 30 : 2340 – 2348 .
  • Nguyen , J. and Reul , R. 2009 . Nanocomposites of lung surfactant and biodegradable cationic nanoparticles improved transfection efficency to lung cells . J. Control. Release , 140 : 47 – 54 .
  • Zabaleta , V. , Ponchel , G. , Salman , H. , Agueros , M. , Vauthier , C. and Irache , J. M. 2012 . Oral administration of paclitaxel with pegylated poly(anhydride) nanoparticles: Permeability and pharmacokinetic study . Eur. J. Pharm. Biopharm. , 81 : 514 – 523 .
  • Park , J. , Fong , P. M. , Lu , J. , Russell , K. S. , Booth , C. J. , Saltzman , W. M. and Fahmy , T. M. 2009 . PEGylated PLGA nanoparticles for the improved delivery of doxorubicin . Nanomedicine: Nanotech. Biol. and Medicine , 5 : 410 – 418 .
  • Semete , B. , Booysen , L. , Kalombo , L. , Ramalapa , B. , Hayeshi , R. and Swai , H. S. 2012 . Effects of protein binding in the biodistribution of PEGylated PLGA nanoparticles post oral administration . Int. J. Pharm. , 424 : 115 – 120 .
  • Chung , Y. , Chul , J. , Kim , Y. H. , Tae , G. , Lee , S. W. , Kim , K. and Kwon , I. 2010 . The effect of surface functionalization of PLGA nanoparticles by heparin- or chitosan-conjugated Pluronics on tumor targeting . J. Control. Release , 143 : 374 – 382 .
  • Roy , K. , Mao , H. Q. , Huang , S. K. and Leong , K. W. 1999 . Oral gene delivery with chitosan-DNA nanoparticles generates immunologic protection in a murine model of peanut allergy . Nat. Med. , 5 : 387 – 391 .
  • Park , J. H. , Saravanakumar , G. , Kim , K. and Kwon , I. C. 2010 . Targeted delivery of low molecular drugs using chitosan and its derivatives . Adv. Drug Deliver. Rev. , 62 : 28 – 41 .
  • Takeuchi , H. , Thongborisute , J. , Matsui , Y. , Sugihara , H. , Yamamoto , H. and Kawashima , Y. 2005 . Novel mucoadhesion tests for polymers and polymer-coated particles to design optimal mucoadhesive drug delivery systems . Adv. Drug Deliver. Rev. , 57 : 1583 – 1594 .
  • Hosseinzadeh , H. , Atyabi , F. , Dinarvand , R. and Ostad , S. N. 2012 . Chitosan–Pluronic nanoparticles as oral delivery of anticancer gemcitabine: Preparation and in vitro study . Int. J. Nanomedicine. , 7 : 1851 – 1863 .
  • Swami , A. , Shi , J. , Gadde , S. , Votruba , A. R. , Kolishetti , N. and Farokhzad , O. C. “ Nanoparticles for targeted and temporally controlled drug delivery ” . In Multifunctional Nanoparticles for Drug Delivery Applications: Imaging, Targeting, and Delivery , Edited by: Sonke , S. and Robert , K. P. New York : Springer . Chapter 2
  • Ahsan , F. , Rivas , I. P. , Khan , M. A. and Suárez , A. I. T. 2002 . Targeting to macrophages: role of physicochemical properties of particulate carriers-liposomes and microspheres-on the phagocytosis by macrophages . J. Control. Release , 79 ( 1–3 ) : 29 – 40 .
  • Salvador-Morales , C. , Zhang , L. , Langer , R. and Farokhzad , O. C. 2009 . Immuno-compatibility properties of lipid-polymer hybrid nanoparticles with heterogeneous surface functional groups . Biomaterials. , 30 ( 12 ) : 2231 – 2240 .
  • Alexis , F. , Pridgen , E. , Molnar , L. K. and Farokhzad , O. C. 2008 . Factors affecting the clearance and bio-distribution of polymeric nanoparticles . Mol. Pharm. , 5 ( 4 ) : 505 – 515 .
  • Vasir , J. K. and Labhasetwar , V. 2008 . Quantification of the force of nanoparticle–cell membrane interactions and its influence on intracellular trafficking of nanoparticles . Biomaterials. , 29 : 4244 – 4252 .
  • Foged , C. , Brodin , B. , Frokjaer , S. and Sundblad , A. 2005 . Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model . Int. J. Pharm. , 298 : 315 – 322 .
  • Xua , F. , Yuana , Y. and Shana , X. 2009 . Long-circulation of hemoglobin-loaded polymeric nanoparticles as oxygen carriers with modulated surface charges . Int. J. Pharm. , 377 : 199 – 206 .
  • Armstead , A. L. and Li , B. 2011 . Nanomedicine as an emerging approach against intracellular pathogens . Int. J. Nanomedicine. , 6 : 3281 – 3293 .
  • Panyam , J. , Zhou , W. Z. , Prabha , S. , Sahoo , S. K. and Labhasetwar , V. 2002 . Rapid endolysosomal escape of poly(DL-lactide-co-glycolide) nanoparticles: Implications for drug and gene delivery . FASEB J. , 16 : 1217 – 1226 .
  • Liu , J. and Xu , L. 2012 . Preparation and characterization of cationic curcumin nanoparticles for improvement of cellular uptake . Carbohydr. Polym. , 90 : 16 – 22 .
  • Mohammadi , G. , Nokhodchi , A. , Jalali , M. B. , Lotfipour , F. , Adibkia , K. , Ehyaei , N. and Valizadeh , H. 2011 . Physicochemical and anti-bacterial performance characterization of clarithromycin nanoparticles as colloidal drug delivery system . Colloids Surf B Biointerfaces , 88 : 39 – 44 .
  • Nahar , M. , Mishra , D. , Dubey , V. and Jain , N. K. Development of Amphotericin B Loaded PLGA Nanoparticles for Effective Treatment of Visceral Leishmaniasis . Thirteenth International Conference on Biomedical Engineering, IFMBE Proceedings 2009; , Vol. 23 , pp. 1241 – 1243 .
  • Mao , S. , Xu , J. , Cai , C. , Germershaus , O. , Schaper , A. and Kissel , T. 2007 . Effect of WOW process parameters on morphology and burst release of FITC-dextran loaded PLGA microspheres . Int. J. Pharm. , 334 ( 1–2 ) : 137 – 148 .
  • Thomasin , C. , Ho , N. T. , Merkle , H. P. and Gander , B. 1998 . Drug microencapsulation by PLA/PLGA coacervation in the light of thermodynamics: Overview and theoretical considerations . J. Pharm. Sci. , 87 ( 3 ) : 259 – 268 .
  • Park , T. G. 1995 . Degradation of poly (lactic-co-glycolic acid) microspheres: Effect of copolymer composition . Biomaterials , 16 ( 15 ) : 1123 – 1130 .
  • Sinha , V. R. and Trehan , A. 2008 . Development, characterization, and evaluation of ketorolac tromethamine-loaded biodegradable microspheres as a depot system for parenteral delivery . Drug Deliv. , 15 ( 6 ) : 365 – 372 .
  • Vivek , K. , Reddy , L. H. and Murthy , R. S. 2007 . Comparative study of some biodegradable polymers on the entrapment efficiency and release behavior of etoposide from microspheres . Pharm. Dev. Technol. , 12 ( 1 ) : 79 – 88 .
  • Sung , K. C. , Han , R. Y. , Hu , O. Y. P. and Hsu , L. R. 1998 . Controlled release of nalbuphine prodrugs from biodegradable polymeric matrices: influence of prodrug hydrophilicity and polymer composition . Int. J. Pharm. , 172 : 17 – 25 .
  • Chem 421: Introduction to Polymer Chemistry, Polymer Properties and MW . (http://chem.chem.rochester.edu/~chem421/propsmw.htm, (Accessed online Jan 2013)
  • Karavelidis , V. , Giliopoulos , D. , Karavas , E. and Bikiaris , D. 2010 . Nanoencapsulation of a water soluble drug in biocompatible polyesters. Effect of polyesters melting point and glass transition temperature on drug release behavior . Eur. J. Pharm. Sci. , 41 : 636 – 643 .
  • Wu , X. S. 1995 . “ Synthesis and properties of biodegradable lactic/glycolic acid polymers ” . In Encyclopedia Handbook of Biomaterials and Bioengineering , Edited by: Wise . 1151 – 2000 . New York : Marcel Dekker .
  • Lewis , D. H. 1990 . “ Controlled release of bioactive agents from lactide/glycolide polymers ” . In Biodegradble Polymers as Drug Delivery Systems , Edited by: Chasin , M. and Langer , R . 1 – 41 . New York : Marcel Dekker .
  • Park , J. H. , Ye , M. and Park , K. 2005 . Biodegradable polymers for microencapsulation of drugs . Molecules , 10 : 146 – 161 .
  • Karavelidis , V. , Karavas , E. , Giliopoulos , D. , Papadimitriou , S. and Bikiaris , D. 2011 . Evaluating the effects of crystallinity in new biocompatible polyester nanocarriers on drug release behavior . Int. J. Nanomedicine. , 6 : 3021 – 3032 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.